These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32683851)

  • 1. The expression and prognostic significance of Topo-II and c-erbB-2 in breast cancer.
    Hua S; Chuanbo F; Zhonglin W; Shuangjiu Z; Xinwen Z
    Minerva Med; 2020 Jul; ():. PubMed ID: 32683851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
    Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
    Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical value of miR-27a in serum of patients with skin squamous cell carcinoma.
    Wang H; Wang S; Chen F; Zhang C; Zhang X; Sun Y
    J BUON; 2020; 25(5):2515-2522. PubMed ID: 33277877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase IIalpha expression in ductal carcinoma in situ of the breast: a preliminary study.
    Shpitz B; Bomstein Y; Zehavi T; Bernheim J; Liverant S; Kaufman Z; Buklan G; Klein E
    Hum Pathol; 2000 Oct; 31(10):1249-54. PubMed ID: 11070118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human DNA topoisomerase II-alpha.
    Martinchick J; Rahn M; Jolles C; Holden J
    Int J Oncol; 1997 Jun; 10(6):1229-34. PubMed ID: 21533509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer.
    Chen S; Huang L; Liu Y; Chen CM; Wu J; Shao ZM
    Eur J Surg Oncol; 2013 Jun; 39(6):619-26. PubMed ID: 23473851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.
    Järvinen TA; Kononen J; Pelto-Huikko M; Isola J
    Am J Pathol; 1996 Jun; 148(6):2073-82. PubMed ID: 8669491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of HER2 and Topo IIα in breast cancer and 
its clinical significance].
    Shuai P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1143-1147. PubMed ID: 27932758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies in male breast cancer: clinical implications of chromosome 17 gene alterations and molecular subtypes.
    Schildhaus HU; Schroeder L; Merkelbach-Bruse S; Binot E; Büttner R; Kuhn W; Rudlowski C
    Breast; 2013 Dec; 22(6):1066-71. PubMed ID: 24080492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of c-Met is Associated with Chemotherapy-Resistant Breast Cancer and Poor Clinical Outcome.
    Jia L; Yang X; Tian W; Guo S; Huang W; Zhao W
    Med Sci Monit; 2018 Nov; 24():8239-8249. PubMed ID: 30444219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
    O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
    Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF
    Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.
    Durbecq V; Desmed C; Paesmans M; Cardoso F; Di Leo A; Mano M; Rouas G; Leroy JY; Sotiriou C; Piccart M; Larsimont D
    Int J Oncol; 2004 Nov; 25(5):1473-9. PubMed ID: 15492841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.
    Jin J; Zheng D; Liu Y
    Pak J Med Sci; 2017; 33(4):844-848. PubMed ID: 29067051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
    Orlando L; Del Curto B; Gandini S; Ghisini R; Pietri E; Torrisi R; Balduzzi A; Cardillo A; Dellapasqua S; Veronesi P; Viale G; Goldhirsch A; Colleoni M
    Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin.
    Sakurai R; Kaira K; Miura Y; Sunaga N; Saito R; Oyama T; Hisada T; Yamada M
    Thorac Cancer; 2020 Feb; 11(2):426-435. PubMed ID: 31901017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of Topo IIα and Ki67 in breast cancer and its clinicopathologic features and prognosis.
    Sun G; Wang S; Wang Y
    Pak J Med Sci; 2019; 35(3):715-720. PubMed ID: 31258582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.